30
17
th
Congress of the European Society for Sexual Medicine
003 Vasculogenesis and diabetic erectile dysfunction:
How relevant is glycemic control?
Angela Castela, Portugal
P. Gomes, R. Silvestre, L. Guardão, L. Leite,
P. Vendeira, C. Costa
004 Tadalafil ameliorates MetS-induced alterations
by inducing a „Brown-like“ phenotype in visceral
adipose tissue: An experimental study in the
rabbit
Linda Vignozzi, Italy
I. Cellai, A. Aversa, T. Mello, S. Filippi,
P. Comeglio, D. Bani, A. Morelli, M. Maggi
005 Development of a high-throughput, cell-based
assay for anti-myofibroblast activity in Peyronie‘s
disease
William Stebbeds, United Kingdom
M. Mateus, B. Ameyaw, A. Raheem, M. Spi-
lotros, G. Garaffa, A. Muneer, N. Christopher,
S. Cellek, D. Ralph
006 Stimulation of calcium-activated potassium chan-
nels (KCa) as a strategy to modulate enhanced
neurogenic contractions of corpus cavernosum
Javier Angulo, Spain
J. I. Martínez-Salamanca, J. M. La Fuente,
A. Fernández, E. Martínez-Salamanca,
A. J. Pepe-Cardoso, J. Carballido
007 Synergistic effects of Y-27632 and vardenafil
on relaxation of corpus cavernosum tissue of
patients with erectile dysfunction and clinical
phosphodiesterase type 5 inhibitor failure
Pieter Uvin, Belgium
M. Albersen, I. Bollen, M. Falter, L. Linsen,
H. Tinel, P. Sandner, T. Bivalacqua, D. de Rid-
der, F. van der Aa, B. Brône, K. van Renterghem
008 Role of SK3 channes in erectile function in mice
Simon Comerma Steffensen, Denmark
A. Kun, E. Hedegaard, B. Mønster Christen-
sen, S. Mogensen, C. Aalkjaer, R. Kohler,
U. Simonsen
009 Influence of vardenafil on sperm hyperactivation
Fotios Dimitriadis, Greece
P. Tsounapi, S. Skouros, S. Stavrou, S. Tomita,
A. Takenaka, N. Sofikitis
010 The beneficial effect of intracavernosal fesotero-
dine (competitive muscarinic receptor antago-
nist) on erectile dysfunction of diabetic rats
Serap Gur, Turkey
D. Yilmaz, E. Kaya, D. Yilmaz
011 Antioxidant therapy with alga ecklonia bicyclis,
tribulus terrestris, glucosamine oligosaccharide
and myo-inositol reduces oxidative stress, lipid
peroxidation and DNA-fragmentation in men
with oligoasthenozoospermia
Fabrizio Iacono, Italy
A. Ruffo, D. Prezioso, G. Romeo, E. Illiano,
L. Romis, G. Di Lauro
012 Tadalafil restores penile neuronal nitric oxide
synthase levels which decreases with chronic
paroxetine treatment
Ege Can Serefoglu, Turkey
A. Gul, L. Kabasakal, D. S. Celik,
A. Semercioz
013 Nerves and vessels in the corpora cavernosa and
corpus spongiosum. Analysis of their develop-
ment in the human penis during the whole fetal
period
Carla Gallo, Brazil
W. Costa, B. Gregorio, F. Sampaio
NS-07
National Symposium
13:30–16:15
Room 18/19
Scandinavian Society for Sexual Medicine: Sexual
function in cancer patients and SSSM General
Assembly
001 Introduction and status of the Congress and the
SSSM
Mikkel Fode, Denmark
002 Genital cancer, male identity and couples’ sexual
satisfaction
Luca Incrocci, The Netherlands
003 Sexual function in androgen deprivation therapy
Peter Østergren, Denmark
004 Cancer and female sexual dysfunction
Gideon Sartorius, Switzerland
English language only
SSSM General Assembly (in Scandinavian language)
ML-07
Master Lecture
15:00–15:30
Auditorium 15
What happened to good old Masters & Johnson? An
update on pharmacological and non-pharmacological
PE treatment in 2015
Chair:
Ege Can Serefoglu, Turkey
Speaker: Chris G. McMahon, Australia
15:30–16:00
Break
Scientific Program l
Saturday, 7 February 2015
